CSIMarket
 


Viewray Inc.  (VRAY)
Other Ticker:  
 

Viewray's Working Capital Ratio

VRAY's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




VRAY Working Capital Ratio (Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Current Liabilities Change -6.22 % -22.4 % -15.56 % -3.65 % 53.36 %
Y / Y Current Assets Change 11.41 % -12.05 % -9.91 % -28.04 % 29.66 %
Working Capital Ratio MRQ 3.72 4.42 5.13 3.94 3.13
Overall Ranking # 678 # 0 # 1587 # 914 # 767
Seq. Current Liabilities Change 43.88 % 7.71 % -13.55 % -30 % 19.06 %
Seq. Current Assets Change 21.07 % -7.28 % 12.54 % -11.82 % -4.42 %



Working Capital Ratio forth quarter 2021 Comment
Due to increase in Current Liabilities in the forth quarter 2021, Working Capital Ratio fell to 3.72 below Viewray Inc. average.

Within Medical Equipment & Supplies industry 53 other companies have achieved higher Working Capital Ratio than Viewray in forth quarter 2021. While Working Capital Ratio total ranking has deteriorated compare to the prior quarter from 0 to 678.

Explain Working Capital Ratio
Where is VRAY most successful ?
Working Capital Ratio VRAY on the trailing twelve month basis
Working Capital Ratio forth quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 54
Healthcare Sector # 241
Overall Market # 678


Working Capital Ratio Statistics
High Average Low
6.47 3.22 0.97
(Sep 30 2018)   (Dec 31 2016)




Financial Statements
Viewray's Current Liabilities $ 76 Millions Visit VRAY's Balance sheet
Viewray's Current Assets $ 284 Millions Visit VRAY's Balance sheet
Source of VRAY's Sales Visit VRAY's Sales by Geography


Cumulative Viewray's Working Capital Ratio

VRAY's Working Capital Ratio for the trailling 12 Months

VRAY Working Capital Ratio

(Dec 31 2021)
IV. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Current Liabilities TTM Growth -6.22 % -22.4 % -15.56 % -3.65 % 53.36 %
Y / Y Current Assets TTM Growth 11.41 % -12.05 % -9.91 % -28.04 % 29.66 %
Working Capital Ratio TTM 4.23 4.02 3.9 3.87 4.17
Total Ranking TTM # 1326 # 0 # 0 # 0 # 0
Seq. Current Liabilities TTM Growth 43.88 % 7.71 % -13.55 % -30 % 19.06 %
Seq. Current Assets TTM Growth 21.07 % -7.28 % 12.54 % -11.82 % -4.42 %


TTM Working Capital Ratio Comment
On the trailing twelve months basis VRAY Current Assets average increased by 11.41 % in IV. Quarter year on year, while Current Liabilities soared to $76 millions, this led to increase in in Viewray's Working Capital Ratio to 4.23, Working Capital Ratio remained below VRAY average.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 97 other companies have achieved higher Working Capital Ratio than Viewray. While overall ranking remained unchanged compare to previous quarter at no. 1326.

Explain Working Capital Ratio
Where is VRAY most successful ?
Working Capital Ratio VRAY on the trailing twelve month basis

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 98
Healthcare Sector # 606
Within the Market # 1326


TTM Working Capital Ratio Statistics
High Average Low
4.87 3.7 1.49
(Jun 30 2019)   (Jun 30 2017)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2021, within Medical Equipment & Supplies Industry Working Capital RatioDec 31 2021 MRQ Current AssetsDec 31 2021 MRQ Current Liabilities
Assure Holdings Corp   10.22 $ 38.003  Millions$ 3.717  Millions
Vivos Inc  9.79 $ 1.634  Millions$ 0.167  Millions
Better Therapeutics Inc   9.56 $ 45.251  Millions$ 4.733  Millions
Privia Health Group Inc   9.53 $ 446.676  Millions$ 46.860  Millions
Motus Gi Holdings Inc   9.24 $ 23.961  Millions$ 2.594  Millions
Co diagnostics Inc   9.14 $ 115.119  Millions$ 12.598  Millions
Abiomed Inc   8.68 $ 885.006  Millions$ 101.929  Millions
Endra Life Sciences Inc   8.57 $ 12.094  Millions$ 1.411  Millions
Inspiremd Inc   8.53 $ 37.094  Millions$ 4.347  Millions
Nuwellis Inc   8.50 $ 28.126  Millions$ 3.307  Millions
Invivo Therapeutics Holdings Corp   8.50 $ 19.142  Millions$ 2.251  Millions
Polypid Ltd   8.42 $ 34.811  Millions$ 4.136  Millions
Fonar Corporation  8.13 $ 111.601  Millions$ 13.724  Millions
Icecure Medical Ltd   7.99 $ 30.322  Millions$ 3.796  Millions
Koru Medical Systems Inc   7.95 $ 37.321  Millions$ 4.696  Millions
Outset Medical Inc   7.93 $ 409.802  Millions$ 51.695  Millions
Apollo Endosurgery inc   7.92 $ 114.700  Millions$ 14.486  Millions
Glaukos Corp  7.67 $ 486.126  Millions$ 63.360  Millions
Neuronetics Inc   7.67 $ 115.331  Millions$ 15.033  Millions
Alpha Tau Medical Ltd   7.41 $ 32.641  Millions$ 4.405  Millions
Petvivo Holdings Inc   7.27 $ 8.048  Millions$ 1.106  Millions
Sonendo Inc   7.23 $ 98.859  Millions$ 13.677  Millions
Brainsway Ltd   7.22 $ 65.447  Millions$ 9.067  Millions
Electromed inc   6.95 $ 32.450  Millions$ 4.670  Millions
Electrocore Inc   6.92 $ 37.541  Millions$ 5.424  Millions
Glucotrack Inc   6.91 $ 6.105  Millions$ 0.883  Millions
Acutus Medical Inc   6.82 $ 126.290  Millions$ 18.510  Millions
Inovio Pharmaceuticals Inc.  6.82 $ 448.445  Millions$ 65.742  Millions
Sintx Technologies Inc   6.79 $ 15.028  Millions$ 2.214  Millions
Nephros Inc   6.73 $ 13.634  Millions$ 2.026  Millions

Date modified: 2022-08-04T16:59:14+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SST's Profile

Stock Price

SST's Financials

Business Description

Fundamentals

Charts & Quotes

SST's News

Suppliers

SST's Competitors

Customers & Markets

Economic Indicators

SST's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071